Amplia Therapeutics Limited carries a market capitalization of 59.03M, placing it among publicly traded companies globally.
| Market Cap | 59.03M |
| Enterprise Value | N/A |
Amplia Therapeutics Limited's stock has declined approximately -48.88889% over the past 52 weeks. The 50-day moving average sits at 0.10, while the 200-day moving average is 0.10.
| Beta (5Y) | N/A |
| 52-Week Price Change | -48.88889% |
| 50-Day Moving Average | 0.10 |
| 200-Day Moving Average | 0.10 |
| Average Volume (20 Days) | N/A |
Amplia Therapeutics Limited's most recent stock split took place on April 23, 2024 with a 250:257 split ratio.
| Last Split Date | 4/23/2024 |
| Split Ratio | 250:257 |